Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-04-04 18:00 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 244.4 KB | ||
| 2022-03-31 17:45 |
Amoéba 2021 results: further development of biocidal and biocontrol applications
|
English | PDF • 294.3 KB | ||
| 2022-03-31 17:45 |
Résultats Amoéba 2021 : poursuite du développement des applications biocide et …
|
French | PDF • 320.2 KB | ||
| 2022-03-25 17:45 |
Amoéba: update of the European regulatory application calendar.
|
English | PDF • 244.2 KB | ||
| 2022-03-25 17:45 |
Amoéba : mise à jour du calendrier des dossiers règlementaires européens
|
French | PDF • 263.4 KB | ||
| 2022-03-07 17:45 |
Amoéba : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 246.0 KB | ||
| 2022-03-07 17:45 |
AMOEBA annonce l’émission de la quatrième tranche de 60 obligations convertible…
|
French | PDF • 397.2 KB | ||
| 2022-03-07 17:45 |
AMOEBA announces the issuance of the fourth tranche of 60 bonds convertible int…
|
English | PDF • 307.3 KB | ||
| 2022-02-02 17:45 |
Déclaration du nombre total de droits de vote et du nombre d’actions composant …
|
French | PDF • 226.5 KB | ||
| 2022-01-25 17:45 |
AMOEBA renforce son conseil d’administration en cooptant une nouvelle administr…
|
French | PDF • 255.2 KB | ||
| 2022-01-25 17:45 |
AMOEBA strengthens its board of directors by co-opting a new director
|
English | PDF • 259.5 KB | ||
| 2022-01-11 17:45 |
AMOEBA CONFIRME SON ELIGIBILITE AU DISPOSITIF PEA-PME
|
French | PDF • 197.4 KB | ||
| 2022-01-07 17:45 |
Amoeba : Report de l’émission de la 4ème tranche d’OCA
|
English | PDF • 260.4 KB | ||
| 2022-01-07 17:45 |
Amoéba: Deferral of the 4th tranche of OCAs
|
French | PDF • 246.1 KB | ||
| 2022-01-04 17:45 |
AMOEBA : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
|
French | PDF • 378.2 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
